MindWalk Holdings Corp. (IPA)
NASDAQ (CM) NASDAQ (CM) Primary 
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.02.
ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock?
ImmunoPrecise Antibodies (IPA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ImmunoPrecise Antibodies Ltd. (IPA) Q3 2025 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q3 2025 Earnings Conference Call March 28, 2025 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer and President Joseph Scheffler - Interim Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate.
IPA to Present at The Microcap Conference 2025
VICTORIA, BC / ACCESSWIRE / December 19, 2024 / IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") (NASDAQ:IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors.
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret
QGEN announces the launch of IPA Interpret to extend the analysis capabilities of a human-curated knowledge base with AI technology.
ImmunoPrecise Antibodies Ltd. (IPA) Q2 2025 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q2 2025 Earnings Conference Call December 10, 2024 10:30 AM ET Company Participants Jennifer Bath - CEO Kristin Taylor - CFO Conference Call Participants Swayampakula Ramakanth - H.C.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q2 Loss, Misses Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05.
ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q1 2025 Earnings Conference Call September 16, 2024 10:30 AM ET Company Participants Jennifer Bath - CEO Kristin Taylor - CFO Conference Call Participants Swayampakula Ramakanth - H.C.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q1 Loss, Misses Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.09.
ImmunoPrecise Antibodies Ltd. (IPA) Q4 2024 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q4 2024 Earnings Conference Call July 29, 2024 10:30 AM ET Company Participants Jennifer Bath - Chief Executive Officer Kristin Taylor - Chief Financial Officer Conference Call Participants Will McHale - Ingalls & Snyder Swayampakula Ramakanth - H.C.
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
ImmunoPrecise Antibodies Ltd. (IPA) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.10.
